EMA Can Do More With Its Guidance On Multiplicity Issues In Clinical Trials, Says EFPIA

 
• By Vibha Sharma
  
Clinical trial
EFPIA Suggests Improvements To EMA’s Guidance On Multiplicity Issues In Trials • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D